Radioligand Therapies

Radioligand therapy (RLT) allows the delivery of radioactive particles to cells within a tumor. The decay of radionuclides releases radiation, killing both the cells to which they are bound as well as nearby cells. RLTs are a promising modality to target cancer-associated proteins that are not amenable to treatment with ADCs.